The Aviation Medication Transparency Act of 2025 requires the FAA to create and regularly update a public list of medications that pilots and air traffic controllers can safely take while seeking medical certification. This is intended to provide clear guidance, as there is currently no official list of approved medications, although there are lists of medications that should not be prescribed or used while flying.
H.R. 2592 was introduced in the 119th Congress by Sean Casten (Democrat) and is currently listed as “Reported by Committee”. It is classified under the Transportation and Public Works policy area, one of 162 bills in that area we track this Congress.
Sean Casten is the sponsor of 6 bills in our database this Congress, so H.R. 2592 is part of a broader legislative agenda rather than a one-off proposal.
Our conflict-of-interest analysis rates H.R. 2592 2/10 (low risk), higher than 76% of analyzed bills; the average in Transportation and Public Works is 2.1/10.
Supporters of the Aviation Medication Transparency Act of 2025 have praised it for promoting safety and clarity within the aviation industry. The establishment of a clear list of approved medications is seen as a step forward in ensuring that pilots and air traffic controllers can make informed decisions about their health without jeopardizing safety. Advocates argue that this transparency will enhance public confidence in aviation operations.
Critics of the Aviation Medication Transparency Act of 2025 have raised concerns about the potential implications of creating such a list. Some argue that it could lead to over-reliance on medications that may not be suitable for all individuals, potentially compromising safety. Others worry that the FAA might face pressure from pharmaceutical companies to include certain medications, which could conflict with the agency's primary focus on safety.
The Aviation Medication Transparency Act of 2025, sponsored by Sean Casten, does not exhibit any direct industry overlaps with his top donor industries, which include Health Professionals and Retired individuals. The significant contributions from Health Professionals, totaling $120 million, primarily come from individuals rather than PACs, indicating a personal investment in the sponsor rather than a corporate agenda. The Retired category, contributing $37.5 million, also does not align with the aviation medication focus of the bill. Given the absence of direct financial ties between the bill's subject matter and the sponsor's major donors, the potential for conflicts of interest appears minimal. Voters should be aware that while large donations can raise questions about influence, in this case, the lack of direct overlap suggests a lower risk of legislative bias.
Top industries funding Sean Casten, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
What does H.R. 2592 do?
The Aviation Medication Transparency Act of 2025 requires the FAA to create and regularly update a public list of medications that pilots and air traffic controllers can safely take while seeking medical certification. This is intended to provide clear guidance, as there is currently no official list of approved medications, although there are lists of medications that should not be prescribed or…
Has H.R. 2592 received a floor vote?
No roll-call vote on H.R. 2592 is recorded in our database yet. Its current status is “Reported by Committee”.
Does H.R. 2592 have a conflict of interest?
Our conflict-of-interest analysis rates H.R. 2592 2/10 (low risk), higher than 76% of analyzed bills; the average in Transportation and Public Works is 2.1/10. This score reflects overlap between the sponsor’s campaign funding, lobbying activity, and the industries the bill affects. It is a transparency indicator, not an accusation.
What is the status of H.R. 2592?
H.R. 2592 is currently “Reported by Committee” as of our last update on September 16, 2026.
Who sponsored H.R. 2592?
H.R. 2592 was sponsored by Sean Casten (Democrat).
